← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2002Last known activity
Feb 1, 2023
Timeline
1950s
- Jan 1, 1959
Universitair Ziekenhuis Gent— Founded
Drugs by trial phase (25 distinct, 21 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Carcinoma, Non-Small-Cell Lung
- Colitis
- Colitis, Ulcerative
- Cytomegalovirus Infections
- Graft vs Host Disease
- Hodgkin Disease
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Nasopharyngeal Carcinoma
- Neuralgia
- Osteoarthritis
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Rhinitis, Allergic, Seasonal
- Spondylarthritis
- Ulcer
- Urinary Bladder Neoplasms
- Urticaria
Recent trials (21)
- NCT05440201Overall official - principal investigatorN/AFeb 1, 2023
- NCT05570123Overall official - principal investigatorN/ASep 14, 2022
- NCT04893655Overall official - principal investigatorPhase 4May 3, 2021
- NCT04625114Overall official - principal investigatorPhase 2Nov 4, 2020
- NCT04435288Overall official - principal investigatorPhase 3Jul 1, 2020
- NCT04987372Overall official - principal investigatorPhase 4Sep 1, 2019
- NCT03965117Overall official - principal investigatorPhase 4May 29, 2019
- NCT03772106Overall official - principal investigatorPhase 4Jun 8, 2017
- NCT03767296Overall official - principal investigatorPhase 4Feb 6, 2017
- NCT02798692Overall official - principal investigatorPhase 1Jun 1, 2016
- NCT02771860Overall official - principal investigatorPhase 2Mar 1, 2016
- NCT02560948Overall official - principal investigatorPhase 3Dec 1, 2015
- NCT02759250Overall official - principal investigatorPhase 1Feb 1, 2015
- NCT01821235Overall official - principal investigatorPhase 1Apr 1, 2013
- NCT01308021Overall official - principal investigatorPhase 2Dec 1, 2010
Details
- Founded
- Ghent, BE Jan 1, 1959
- Last known activity
- Feb 1, 2023